5-Fluorouracil ∼99%, powder

Supplier: MP Biomedicals

Synonyms: Fluorouracil, 5-Fluoropyrimidine-2,4(1H,3H)-dione, 5-FU

0210172210 0210172201 0210172205
ICNA0210172210EA 146 EUR
ICNA0210172210 ICNA0210172201 ICNA0210172205
5-Fluorouracil ∼99%, powder
5-Fluorouracil

5-Fluorouracil (5-FU) inhibits the activity of thymidylate synthetase, which affects pyrimidine synthesis and leads to depletion of intracellular TTP pools.


5-FU has also been proposed to interfere with the activity of ribosomal RNA binding protein (RRBP), at the level of pre-ribosomal RNA (pre-rRNA) processing. 5-Fluorouracil is a potent agent against solid tumors that was introduced in 1957 for clinical use. It remains one of the most effective chemotherapeutic agents in such conditions as colorectal cancer, even at its limited response rates (10 to 30%).


A potent antitumor agent that affects pyrimidine synthesis by inhibiting thymidylate synthetase thus depleting intracellular dTTP pools. It is metabolized to ribonucleotides and deoxyribonucleotides, which can be incorporated into RNA and DNA. Treatment of cells with 5-FU leads to an accumulation of cells in S-phase and has been shown to induce p53 dependent apoptosis.


Soluble in 1 M Ammonium Hydroxide (50 mg per ml), 1M NaOH and DMSO (10 to 50 mg/ml)/DMF.


Caution: Research Use Only (RUO).

Formula: C₄H₃FN₂O₂
MW: 130,08 g/mol
MDL Number: MFCD00006018
CAS Number: 51-21-8
UN: 2811
ADR: 6.1,III

Order Now

Specification Test Results

Identity Test Passes
Purity ~99%
FTIR Conforms to Standard
Melting Point 278 - 286 °C

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR